VeriChip Corporation has selected Raytheon Microelectronics España/ECLAN for the production of the company’s implantable microchips, including the chip used in its HealthLink patient identification system, its new eight millimeter microchip for use in Medical Components Inc.’s vascular access medical devices, and its glucose-sensing RFID microchip under development with RECEPTORS LLC.
In December 2008, VeriChip purchased all intellectual property related to its implantable RFID business line from Digital Angel Corporation and canceled its manufacturing relationship. After searching for a new manufacturing partner, VeriChip landed on ELCAN Optical Technologies, a provider of optical and electronic solutions for medical, defense & security and commercial customers, and part of the Raytheon Network Centric Systems group of companies.
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025
